Literature DB >> 30734882

Acceptability and Predictors of Uptake of Anti-retroviral Pre-exposure Prophylaxis (PrEP) Among Fishing Communities in Uganda: A Cross-Sectional Discrete Choice Experiment Survey.

Monica O Kuteesa1,2, Mathew Quaife3, Sam Biraro4, Kenneth R Katumba5, Janet Seeley3,5, Anatoli Kamali6,7, Damalie Nakanjako8,9.   

Abstract

We used a discrete choice experiment to assess the acceptability and potential uptake of HIV pre-exposure prophylaxis (PrEP) among 713 HIV-negative members of fishing communities in Uganda. Participants were asked to choose between oral pill, injection, implant, condoms, vaginal ring (women), and men circumcision. Product attributes were HIV prevention effectiveness, sexually transmitted infection (STI) prevention, contraception, waiting time, and secrecy of use. Data were analysed using mixed multinomial logit and latent class models. HIV prevention effectiveness was viewed as the most important attribute. Both genders preferred oral PrEP. Women least preferred the vaginal ring and men the implant. Condom use was predicted to decrease by one third among men, and not to change amongst women. Oral PrEP and other new prevention technologies are acceptable among fishing communities and may have substantial demand. Future work should explore utility of multiple product technologies that combine contraception with HIV and other STI prevention.

Entities:  

Keywords:  Discrete choice experiment; Fisherfolk; HIV prevention; Pre-exposure prophylaxis; Uganda

Mesh:

Substances:

Year:  2019        PMID: 30734882     DOI: 10.1007/s10461-019-02418-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  13 in total

1.  Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices.

Authors:  Sarah K Calabrese; Rachel W Galvao; John F Dovidio; Tiara C Willie; Cara B Safon; Clair Kaplan; Abigail Caldwell; Oni Blackstock; Nicole J Phillips; Trace S Kershaw
Journal:  AIDS Patient Care STDS       Date:  2020-03       Impact factor: 5.078

2.  Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment.

Authors:  Erica N Browne; Elizabeth T Montgomery; Carol Mansfield; Marco Boeri; Brennan Mange; Mags Beksinska; Jill L Schwartz; Meredith R Clark; Gustavo F Doncel; Jenni Smit; Zvavahera M Chirenje; Ariane van der Straten
Journal:  AIDS Behav       Date:  2020-05

3.  Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis.

Authors:  Jennifer B Griffin; Kathleen Ridgeway; Elizabeth Montgomery; Kristine Torjesen; Rachel Clark; Jill Peterson; Rachel Baggaley; Ariane van der Straten
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

4.  An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose).

Authors:  Katherine Gill; Anna-Ursula Happel; Tanya Pidwell; Andrea Mendelsohn; Menna Duyver; Leigh Johnson; Landon Meyer; Catherine Slack; Ann Strode; Eve Mendel; Lauren Fynn; Melissa Wallace; Hans Spiegel; Heather Jaspan; Jo-Ann Passmore; Sybil Hosek; Dionne Smit; Alex Rinehart; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

5.  Eliciting Preferences for HIV Prevention Technologies: A Systematic Review.

Authors:  S Wilson Beckham; Norah L Crossnohere; Margaret Gross; John F P Bridges
Journal:  Patient       Date:  2020-12-15       Impact factor: 3.883

6.  Perceived access to PrEP as a critical step in engagement: A qualitative analysis and discrete choice experiment among young men who have sex with men.

Authors:  Elizabeth A Asiago-Reddy; John McPeak; Riccardo Scarpa; Amy Braksmajer; Nicola Ruszkowski; James McMahon; Andrew S London
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

7.  Preferences for pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women at risk of HIV infection: a multicentre protocol for a discrete choice experiment in Brazil.

Authors:  Claudia Cristina de Aguiar Pereira; Thiago Silva Torres; Paula Mendes Luz; Brenda Hoagland; Alessandro Farias; Jose David Urbaez Brito; Marcus Vinícius Guimarães Lacerda; Daila Alena Raenck da Silva; Marcos Benedetti; Maria Cristina Pimenta; Beatriz Grinsztejn; Valdilea Gonçalves Veloso
Journal:  BMJ Open       Date:  2021-09-27       Impact factor: 2.692

8.  Factors associated with willingness to use oral pre-exposure prophylaxis (PrEP) in a fisher-folk community in peri-urban Kampala, Uganda.

Authors:  Bashir Ssuna; Anne Katahoire; Mari Armstrong-Hough; Dennis Kalibbala; Joan N Kalyango; Flavia Matovu Kiweewa
Journal:  BMC Public Health       Date:  2022-03-09       Impact factor: 3.295

9.  A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.

Authors:  Jane M Simoni; Kenneth Tapia; Sung-Jae Lee; Susan M Graham; Kristin Beima-Sofie; Zahra H Mohamed; Joan Christodoulou; Rodney Ho; Ann C Collier
Journal:  AIDS Behav       Date:  2020-04

10.  Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.

Authors:  Alexandra M Minnis; Millicent Atujuna; Erica N Browne; Sheily Ndwayana; Miriam Hartmann; Siyaxolisa Sindelo; Nangamso Ngcwayi; Marco Boeri; Carol Mansfield; Linda-Gail Bekker; Elizabeth T Montgomery
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.